1. Home
  2. FEMY vs LBGJ Comparison

FEMY vs LBGJ Comparison

Compare FEMY & LBGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • LBGJ
  • Stock Information
  • Founded
  • FEMY 2004
  • LBGJ 2007
  • Country
  • FEMY United States
  • LBGJ China
  • Employees
  • FEMY N/A
  • LBGJ N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • LBGJ
  • Sector
  • FEMY Health Care
  • LBGJ
  • Exchange
  • FEMY Nasdaq
  • LBGJ NYSE
  • Market Cap
  • FEMY 29.9M
  • LBGJ 24.7M
  • IPO Year
  • FEMY 2021
  • LBGJ 2024
  • Fundamental
  • Price
  • FEMY $0.92
  • LBGJ $1.55
  • Analyst Decision
  • FEMY Strong Buy
  • LBGJ
  • Analyst Count
  • FEMY 3
  • LBGJ 0
  • Target Price
  • FEMY $8.67
  • LBGJ N/A
  • AVG Volume (30 Days)
  • FEMY 257.9K
  • LBGJ 20.0K
  • Earning Date
  • FEMY 08-07-2025
  • LBGJ 08-15-2025
  • Dividend Yield
  • FEMY N/A
  • LBGJ N/A
  • EPS Growth
  • FEMY N/A
  • LBGJ N/A
  • EPS
  • FEMY N/A
  • LBGJ N/A
  • Revenue
  • FEMY $1,699,232.00
  • LBGJ $11,781,015.00
  • Revenue This Year
  • FEMY $283.83
  • LBGJ N/A
  • Revenue Next Year
  • FEMY $161.03
  • LBGJ N/A
  • P/E Ratio
  • FEMY N/A
  • LBGJ N/A
  • Revenue Growth
  • FEMY 61.97
  • LBGJ 21.82
  • 52 Week Low
  • FEMY $0.69
  • LBGJ $1.02
  • 52 Week High
  • FEMY $1.80
  • LBGJ $5.50
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 46.22
  • LBGJ N/A
  • Support Level
  • FEMY $0.91
  • LBGJ N/A
  • Resistance Level
  • FEMY $0.99
  • LBGJ N/A
  • Average True Range (ATR)
  • FEMY 0.05
  • LBGJ 0.00
  • MACD
  • FEMY 0.00
  • LBGJ 0.00
  • Stochastic Oscillator
  • FEMY 11.71
  • LBGJ 0.00

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About LBGJ LI BANG INTERNATIONAL CORPORATION I

Li Bang International Corp Inc is a holding company. The firm through its subsidiaries engages in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China under its own Libang brand. In addition, its subsidiaries provide customers with comprehensive services, from commercial kitchen design in the early stage to equipment installation and after-sales maintenance.

Share on Social Networks: